News Category
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a pivotal step toward a potential neuroprotective therapy for multiple...
PX1 Research's adoption of seven-stage HPLC purity testing and cGMP compliance for all US-made research peptides enhances supply chain transparency fo...
NanoViricides has received approval to begin a Phase II trial of its oral NV-387 gummies for Ebola in the DRC, potentially offering a more practical t...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 trials marks a pivotal step toward a novel neuroprotective treatment for multiple s...
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million driven by TONMYA sales, marking a significant commercial milestone and supporting its p...
Tonix Pharmaceuticals' Q2 2026 revenue jumped to $13.5 million, driven by strong TONMYA sales, signaling commercial success and pipeline progress.
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through clinical trials, FDA submission preparation, European comme...
Quantum BioPharma is progressing its pipeline with Lucid-MS for multiple sclerosis and unbuzzd for alcohol misuse, highlighting a two-pronged approach...
Quantum BioPharma is advancing a two-pronged approach to neurological health, with its MS drug candidate Lucid-MS and its supplement unbuzzd, highligh...
VERAXA Biotech's proprietary BiTAC platform positions it to capitalize on the growing antibody therapeutics market, attracting potential partnerships ...
A case in Spain where a patient's pork tapeworm infection mimicked brain cancer underscores the importance of proper food preparation and the need for...
VERAXA Biotech's VXA-222 bispecific ADC program moves to next development stage, backed by expanded intellectual property, highlighting progress in it...
A novel liquid biopsy offers a simpler way to predict which advanced lung cancer patients will respond to immunotherapy, potentially improving treatme...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning it for a pivotal P...
Onco-Innovations is combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI to develop ONC010, potentially improving cancer treatment ef...
Researchers at Nagoya University discovered that the ancient protein C3, when produced within tumors, can boost the effectiveness of immunotherapy by ...
VolitionRx's proprietary Capture-Seq technology, which isolates over 99% pure circulating tumor DNA, addresses a critical challenge in liquid biopsy a...
Tonix Pharmaceuticals' participation in key investor conferences underscores its strategic focus on advancing its CNS and immunology pipeline, includi...
VERAXA Biotech's VXA-222 bispecific ADC program moves past discovery, and the company expands its IP estate with new patent filings, strengthening its...
NeuroThera Labs has initiated a Phase IIb clinical trial at Yale Child Study Center for SCI-110, a novel cannabinoid-based treatment for Tourette Synd...
SRX Global's investment in Vistagen underscores its strategy to unlock value in undervalued biopharmaceutical companies, potentially reshaping the neu...
SRX Global's acquisition of a stake in Vistagen Therapeutics signals a strategic investment in a late-stage neuroscience biopharmaceutical company, po...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital has reached the halfway point of enrollment, showing promising prelimin...
Biotech Labz Supply Inc has broadened its offerings to 11 documented research peptides, including BPC-157 and Tesamorelin, each with batch-specific ce...
Oncotelic Therapeutics will showcase its progress in cancer therapies, including a Phase 1b trial and AI-driven platforms, at the upcoming OTCQB Virtu...
Tonix Pharmaceuticals announced FDA feedback supporting its planned adaptive Phase 2 field study for TNX-4800, a long-acting monoclonal antibody for L...
Recent independent research suggests cross-reactive immune responses from licensed Ebola vaccines may extend to other ebolavirus species, underscoring...
Regentis Biomaterials' GelrinC platform could revolutionize cartilage repair by offering a practical, single-step procedure that addresses a significa...
Quantum BioPharma's pilot MS imaging study with Massachusetts General Hospital shows promising early results, potentially enhancing the development of...
NeuroThera Labs has achieved a milestone by demonstrating a full hybrid quantum-classical workflow for clinical data analytics, processing real-world ...
NeuroOne released a white paper on its StereoCED™ platform, designed to streamline robotic-assisted drug delivery to the brain, addressing scalability...
VERAXA Biotech has appointed Dr. Christoph Erkel as Chief Scientific Officer to lead scientific strategy for its BiTAC platform and pipeline, undersco...
Onco-Innovations Limited closed a CAD$5 million private placement with Sorbie Bornholm LP and Sorbie Investments LLP, with proceeds earmarked for adva...
Lexaria Bioscience Corp. will effect a 1-for-15 reverse stock split on August 3, 2026, to increase its share price above $1.00 and maintain its Nasdaq...
VolitionRx Limited (NYSE American: VNRX) announced mounting clinical evidence supporting its Nu.Q NETs assay as a biomarker for sepsis and NETosis-rel...
Instinct Bio announced a strategic collaboration with INVITRX to manufacture and sell GENREVER cosmetic products in the U.S. and supply exosomes for I...
Renaissance BioScience Corp. appoints Dr. James Tansey, a serial entrepreneur and professor at UBC's Sauder School of Business, to its Board of Direct...
BRAIN Biotech AG's Supervisory Board has appointed Dr. Sven K. Weber as CEO effective October 1, 2026, succeeding Adriaan Moelker, who will retire; We...
VERAXA Biotech has expanded its patent portfolio with new filings covering its BiTAC-TCE and BiTAC-ADC platforms, protecting its technologies through ...
MindBio Therapeutics has completed and delivered its first Edge AI Intoxication and Fatigue Detection Kiosk prototypes, aiming to provide rapid, scala...
VERAXA Biotech has appointed Dr. Christoph Erkel as Chief Scientific Officer to lead the advancement of its BiTAC(R) platform and oncology pipeline to...
VERAXA Biotech AG has expanded its patent portfolio with new filings for its BiTAC-TCE and BiTAC-ADC platforms, strengthening its position in developi...
Greenland Mines (NASDAQ: GRML) announced a Canadian patent for Klotho-based gene therapies targeting neurodegenerative diseases, expanding its IP port...
Quantum BioPharma's executive outlines the dual strategy of advancing Lucid-MS for multiple sclerosis into Phase 2 trials and leveraging the commercia...
VERAXA Biotech shareholders approved key proposals to enhance corporate flexibility and support long-term growth, including a capital band and board e...
Greenland Mines Ltd. received a Canadian patent for its Klotho-based gene therapy targeting neurodegenerative diseases, expanding its IP portfolio and...
NanoViricides has submitted an application to begin a Phase II trial of its oral antiviral NV-387 for the Bundibugyo ebolavirus strain in the DRC, whe...
